Bioceltix S.A. (WSE:BCX)
Poland · Delayed Price · Currency is PLN 81.20
-1.30 (-1.58%)
Feb 24, 2026, 2:03 PM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 406.27 million as of February 24, 2026. Its market cap has decreased by -4.40% in one year.
Market Cap
406.27M
Enterprise Value
382.72M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
81.20
Market Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 406.27M, an increase of 253.16%. That is a compound annual growth rate of 34.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 23, 2026 | 406.27M | 6.31% |
| Dec 30, 2025 | 382.14M | -11.42% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
| Nov 8, 2021 | 115.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ryvu Therapeutics | 615.00M |
| Captor Therapeutics Spolka Akcyjna | 455.57M |
| BIOTON | 376.09M |
| Synthaverse | 260.08M |
| Molecure | 159.26M |
| Mabion | 131.08M |
| Poltreg | 123.12M |
| NanoGroup | 83.71M |